UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
JAZZ PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
472147107
- --------------------------------------------------------------------------------
(CUSIP Number)
June 1, 2007
- --------------------------------------------------------------------------------
(Date of Event which requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13G
- ------------------- -----------------
CUSIP No. 472147107 Page 2 of 8 Pages
- ------------------- -----------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON (ENTITIES ONLY).
Bridger Management, LLC
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) |_|
(b) |X|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 1,319,800
OWNED BY -----------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH: -----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,319,800
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,319,800
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) |_|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.38%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SCHEDULE 13G
- ------------------- -----------------
CUSIP No. 472147107 Page 3 of 8 Pages
- ------------------- -----------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON (ENTITIES ONLY).
Roberto Mignone
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) |_|
(b) |X|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0
-----------------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 1,319,800
OWNED BY -----------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH: -----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,319,800
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,319,800
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) |_|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.38%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 4 of 8 Pages
Item 1(a). Name of Issuer: Jazz Pharmaceuticals, Inc
Item 1(b). Address of Issuer's Principal Executive Offices:
3180 Porter Drive, Palo Alto, CA 94304 United States
Item 2(a, b, c). Name of Persons Filing, Address of Principal Business Office,
Citizenship:
Bridger Management, LLC, a Delaware limited liability company
and Mr. Roberto Mignone ("Mr. Mignone"), each having offices
at 101 Park Avenue - 48th Floor, New York, NY 10178. Mr.
Mignone is a United States citizen.
Item 2(d). Title of Class of Securities: Common Stock, par value $0.0001
per share (the "Common Stock")
Item 2(e). CUSIP Number: 472147107
Item 3. Not Applicable.
Item 4. Ownership.
1. Bridger Management, LLC:
(a) Amount beneficially owned: 1,319,800 shares.
(b) Percent of class: 5.38%. The percentage of Common Stock
reported as beneficially owned is based upon 24,550,554
shares outstanding as reported by the Issuer on its
Prospectus filed on June 1, 2007, pursuant to
Rule-424(b)(4).
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to vote or to direct the vote:
1,319,800 shares
(iii) Sole power to dispose or to direct the disposition
of: 0
(iv) Shared power to dispose or to direct the
disposition of: 1,319,800 shares.
Page 5 of 8 Pages
2. Roberto Mignone
(a) Amount beneficially owned: 1,319,800 shares.
(b) Percent of class (determined as set forth in paragraph
1(b) of this Item 4): 5.38%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to vote or to direct the vote:
1,319,800 shares
(iii) Sole power to dispose or to direct the disposition
of: 0
(iv) Shared power to dispose or to direct the
disposition of: 1,319,800 shares.
The Common Stock reported herein is beneficially owned as a result of the
purchase of such shares by certain accounts managed by Bridger Management, LLC.
Mr. Mignone is the managing member of Bridger Management, LLC.
Item 5. Ownership of Five Percent or less of a Class:
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following [ ].
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
The Common Stock reported herein is held by certain accounts managed
by Bridger Management, LLC. No such interest relates to more than 5%
of the class.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company or
Control Person.
Not Applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not Applicable.
Page 6 of 8 Pages
Item 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
[Signature Page Follows:]
Page 7 of 8 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATED: June 8, 2007
BRIDGER MANAGEMENT, LLC
By: /s/ Roberto Mignone
---------------------------------
Roberto Mignone, Managing Member
/s/ Roberto Mignone
------------------------------------
Roberto Mignone, Individually
Page 8 of 8 Pages
Exhibit 1
JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge and agree that the foregoing statement on
Schedule 13G is filed on behalf of each of the undersigned and that all
subsequent amendments to this statement on Schedule 13G shall be filed on behalf
of each of the undersigned without the necessity of filing additional joint
acquisition statements. The undersigned acknowledge that each shall be
responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning him or it contained therein, but
shall not be responsible for the completeness and accuracy of the information
concerning the others, except to the extent that he or it knows or has reason to
believe that such information is inaccurate.
DATED: June 8, 2007
By: /s/ Roberto Mignone
---------------------------------
Roberto Mignone, individually and
as the managing member of Bridger
Management, LLC